- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabis Gaining Acceptance Across Europe As Policies Change
George McBride joined the Valens GroWorks (CSE:VGW, OTC:VGWCF) Extracted podcast this week to explain the history of cannabis in the United Kingdom.
George McBride joined the Valens GroWorks (CSE:VGW, OTC:VGWCF) Extracted podcast this week to explain the history of cannabis in the United Kingdom, including the progress that has been made over recent years as authorities and legislators warm to the idea of a legal cannabis marketplace. George is the co-founder of Cannabis Europa, one of Europe’s leading cannabis-related conferences. He also started Hanway Associates, a London-based global cannabis consultancy. During the discussion George provided an update on the progress cannabis has made in Europe, touching on Canada’s international influence as a leader in cannabis legalization.
According to McBride, the majority of people in the UK have been hesitant to accept cannabis as medicine, however recent high-profile cases including children and other sick patients have provided a spotlight for those in desperate need of cannabis-based medicines. “Unlike Canada, we don’t have a long history of dispensaries or compassionate access or influential court decisions. None of that stuff happened in the UK,” said McBride. “Canadians should feel pretty blessed about what a willing court system you’ve had, what incredibly strong voices you’ve had in the patient community and the way in which there has been access in large parts of Canada for 20 years.”
To listen to the full Extracted podcast, click here.
Click here to connect with Valens (CSE:VGW, OTC:VGWCF) for an Investor Presentation.Â
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â